Alex S. Friedlaender: search on Z-Library

The world's largest scientific articles store. 70,000,000+ articles for free.

Don't use scam websites

1

BRCA1/BRCA2 germline mutations and chemotherapy-related hematological toxicity in breast cancer patients

Friedlaender, Alex, Vuilleumier, Aurélie, Viassolo, Valeria, Ayme, Aurélie, De Talhouet, Solène, Combes, Jean-Damien, Peron, Julien, Bodmer, Alexandre, Giraud, Sophie, Buisson, Adrien, Bonadona, Valer

Journal:

Breast Cancer Research and Treatment

Year:

2019

Language:

english

File:

PDF, 1017 KB

english, 2019

2

Rethinking the Optimal Duration of Immune Checkpoint Inhibitors in Non-small Cell Lung Cancer Throughout the COVID-19 Pandemic

Friedlaender, Alex, Kim, Chul, Addeo, Alfredo

Journal:

Frontiers in Oncology

Year:

2020

File:

PDF, 297 KB

2020

3

Spectral Absorption Studies of Antihistaminic Drugs1

Friedlaender, Alex S, Friedlaender, Sidney, Vandenbelt, J M

Journal:

The Journal of Investigative Dermatology

Year:

1948

Language:

english

File:

PDF, 284 KB

english, 1948

4

Spectral Absorption Studies of Antihistaminic Drugs1

Friedlaender, Alex S, Friedlaender, Sidney, Vandenbelt, J M

Journal:

The Journal of Investigative Dermatology

Year:

1948

Language:

english

File:

PDF, 693 KB

english, 1948

5

Spectral absorption characteristics of antihistaminic drugs; Relationship to ultraviolet erythema

Alex S. Friedlaender, Sidney Friedlaender, J.M. Vandenbelt

Journal:

Journal of Allergy (-1970 Elsevier Science)

Year:

1949

Language:

english

File:

PDF, 875 KB

english, 1949

6

The effect of pituitary adrenocorticotrophic hormone (ACTH) on histamine intoxication and anaphylaxis in the guinea pig

Sidney Friedlaender, Alex S. Friedlaender

Journal:

Journal of Allergy (-1970 Elsevier Science)

Year:

1950

Language:

english

File:

PDF, 546 KB

english, 1950

7

Oral cortisone therapy in allergic diseases

Sidney Friedlaender, Alex S. Friedlaender

Journal:

Journal of Allergy (-1970 Elsevier Science)

Year:

1951

Language:

english

File:

PDF, 1.04 MB

english, 1951

8

Topical use of hydrocortisone (compound F) ointment in allergic dermatoses

Sidney Friedlaender, Alex S. Friedlaender

Journal:

Journal of Allergy (-1970 Elsevier Science)

Year:

1954

Language:

english

File:

PDF, 91 KB

english, 1954

9

Topical use of hydrocortisone and hydrocortisoneneomycin ointments in allergic dermatoses

Sidney Friedlaender, Alex S. Friedlaender

Journal:

Journal of Allergy (-1970 Elsevier Science)

Year:

1954

Language:

english

File:

PDF, 1006 KB

english, 1954

10

Clinical effects of ragweed antigen emulsion: A double-blind study

Sidney Friedlaender, Alex S. Friedlaender

Journal:

Journal of Allergy (-1970 Elsevier Science)

Year:

1962

Language:

english

File:

PDF, 644 KB

english, 1962

11

Observations on basophil degranulation as an indicator of antigen-antibody reaction

Sidney Friedlaender, Alex S. Friedlaender

Journal:

Journal of Allergy (-1970 Elsevier Science)

Year:

1964

Language:

english

File:

PDF, 774 KB

english, 1964

12

Parenteral benadryl in allergy

Sidney Friedlaender, Alex S. Friedlaender

Journal:

The American Journal of Medicine

Year:

1948

Language:

english

File:

PDF, 289 KB

english, 1948

13

Antihistamine Agents in Allergy

Friedlaender, Sidney, Friedlaender, Alex S.

Journal:

American Journal of Clinical Pathology

Year:

1950

Language:

english

File:

PDF, 147 KB

english, 1950

14

THE USE OF A HISTAMINE ANTAGONIST, BETA-DIMETHYLAMINETHYL BENZHYDRYL ETHER HYDROCHLORIDE, IN ALLERGIC DISEASE*

Friedlaender, Alex S.

Journal:

The American Journal of the Medical Sciences

Year:

1946

File:

PDF, 939 KB

1946

15

GAMMA GLOBULIN IN THE MANAGEMENT OF ASTHMA ASSOCIATED WITH INFECTION

FRIEDLAENDER, SIDNEY, FRIEDLAENDER, ALEX S., WEINER, LAWRENCE

Journal:

The American Journal of the Medical Sciences

Year:

1959

File:

PDF, 405 KB

1959

16

Immune Checkpoint Inhibitor-Associated Myocarditis: A New Challenge for Cardiologists

Frigeri, Mauro, Meyer, Philippe, Banfi, Carlo, Giraud, Raphaël, Hachulla, Anne-Lise, Spoerl, David, Friedlaender, Alex, Pugliesi-Rinaldi, Angela, Dietrich, Pierre-Yves

Journal:

Canadian Journal of Cardiology

Year:

2018

Language:

english

File:

PDF, 569 KB

english, 2018

17

New emerging targets in cancer immunotherapy: the role of TIM3

Friedlaender, Alex, Addeo, Alfredo, Banna, Giuseppe

Journal:

Year:

2019

Language:

english

File:

PDF, 416 KB

english, 2019

18

Diagnosis and Treatment of ALK Aberrations in Metastatic NSCLC

Friedlaender, Alex, Banna, Giuseppe, Patel, Sandip, Addeo, Alfredo

Journal:

Current Treatment Options in Oncology

Year:

2019

Language:

english

File:

PDF, 998 KB

english, 2019

19

The Activity of Immune Checkpoint Inhibition in KRAS Mutated Non-small Cell Lung Cancer: A Single Centre Experience

TORRALVO, JAVIER, FRIEDLAENDER, ALEX, ACHARD, VERANE, ADDEO, ALFREDO

Journal:

Cancer genomics & proteomics

Year:

2019

Language:

english

File:

PDF, 141 KB

english, 2019

20

Poor-Performance Status Assessment of Patients with Non-small Cell Lung Cancer Remains Vague and Blurred in the Immunotherapy Era

Friedlaender, Alex, Banna, Giuseppe Luigi, Buffoni, Lucio, Addeo, Alfredo

Journal:

Current Oncology Reports

Year:

2019

File:

PDF, 532 KB

2019

21

Identifying successful biomarkers for patients with non-small-cell lung cancer

Friedlaender, Alex, Bauml, Joshua, Banna, Giuseppe Luigi, Addeo, Alfredo

Journal:

Lung Cancer Management

Year:

2019

File:

PDF, 501 KB

2019

22

Prostate cancer non-ascitic peritoneal carcinomatosis after robot-assisted laparoscopic radical prostatectomy: three case reports and review of the literature

Achard, Verane, Achard, Gilles, Friedlaender, Alex, Roth, Arnaud, Tille, Jean-Christophe, Miralbell, Raymond, Zilli, Thomas

Journal:

Year:

2019

File:

PDF, 651 KB

2019

23

KRAS as a druggable target in NSCLC: rising like a phoenix after decades of development failures

Friedlaender, Alex, Drilon, Alexander, Weiss, Glen J., Banna, Giuseppe L., Addeo, Alfredo

Journal:

Cancer Treatment Reviews

Year:

2020

File:

PDF, 1.27 MB

2020

24

Tissue-Plasma TMB Comparison and Plasma TMB Monitoring in Patients With Metastatic Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors

Friedlaender, Alex, Nouspikel, Thierry, Christinat, Yann, Ho, Liza, McKee, Thomas, Addeo, Alfredo

Journal:

Frontiers in Oncology

Year:

2020

File:

PDF, 591 KB

2020

25

How we treat patients with lung cancer during the SARS-CoV-2 pandemic: primum non nocere

Banna, Giuseppe, Curioni-Fontecedro, Alessandra, Friedlaender, Alex, Addeo, Alfredo

Journal:

Year:

2020

File:

PDF, 323 KB

2020

26

Outcomes with immune checkpoint inhibitors for relapsed small-cell lung cancer in a Swiss cohort

Schmid, Sabine, Mauti, Laetitia A., Friedlaender, Alex, Blum, Veronika, Rothschild, Sacha I., Bouchaab, Hasna, FrÃ¶sch, Patrizia, Britschgi, Christian, KÃ¶nig, David, Wannesson, Luciano, Janthur, Wolf

Journal:

Cancer Immunology, Immunotherapy

Year:

2020

File:

PDF, 586 KB

2020

27

Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

Talhouet, Solene De, Peron, Julien, Vuilleumier, Aurelie, Friedlaender, Alex, Viassolo, Valeria, Ayme, AurÃ©lie, Bodmer, Alexandre, Treilleux, Isabelle, Lang, Noemie, Tille, Jean- Christophe, Chappuis

Journal:

Scientific Reports

Year:

2020

File:

PDF, 1.68 MB

2020

28

A BRAF new world

Frisone, Daniele, Friedlaender, Alex, Malapelle, Umberto, Banna, Giuseppe, Addeo, Alfredo

Journal:

Critical Reviews in Oncology/Hematology

Year:

2020

File:

PDF, 1.71 MB

2020

29

Impact of performance status on non-small-cell lung cancer patients with a PD-L1 tumour proportion score â¥50% treated with front-line pembrolizumab

Friedlaender, Alex, Metro, Giulio, Signorelli, Diego, Gili, Alessio, Economopoulou, Panagiota, Roila, Fausto, Banna, Giuseppe, De Toma, Alessandro, Camerini, Andrea, Christopoulou, Athina, Lo Russo, G

Journal:

Acta Oncologica

Year:

2020

File:

PDF, 1.03 MB

2020

30

Immune-related adverse events of pembrolizumab in a large real-world cohort of NSCLC patients with a PD-L1 expression â¥ 50% and their relationship with clinical outcomes.

Cortellini, Alessio, Friedlaender, Alex, Banna, Giuseppe L., Porzio, Giampiero, Bersanelli, Melissa, Cappuzzo, Federico, Aerts, Joachim GJV., Giusti, Raffaele, Bria, Emilio, Cortinovis, Diego, Grossi,

Journal:

Clinical Lung Cancer

Year:

2020

File:

PDF, 693 KB

2020

31

Influence of Concurrent Mutations on Overall Survival in EGFR-mutated Non-small Cell Lung Cancer

CHEVALLIER, MATHIEU, TSANTOULIS, PETROS, ADDEO, ALFREDO, FRIEDLAENDER, ALEX

Journal:

Cancer genomics & proteomics

Year:

2020

File:

PDF, 521 KB

2020

32

Promising predictors of checkpoint inhibitor response in NSCLC

Alex, Friedlaender, Alfredo, Addeo

Journal:

Expert Review of Anticancer Therapy

Year:

2020

File:

PDF, 697 KB

2020

33

Targeted Therapies in Early Stage NSCLC: Hype or Hope?

Friedlaender, Alex, Addeo, Alfredo, Russo, Alessandro, Gregorc, Vanesa, Cortinovis, Diego, Rolfo, Christian D.

Journal:

International Journal of Molecular Sciences

Year:

2020

File:

PDF, 709 KB

2020

34

The METeoric rise of MET in lung cancer

Friedlaender, Alex, Drilon, Alexander, Banna, Giuseppe Luigi, Peters, Solange, Addeo, Alfredo

Journal:

Year:

2020

File:

PDF, 756 KB

2020

35

Tracking the tail

Friedlaender, Alex, Liu, Stephen V, Addeo, Alfredo

Journal:

Journal for ImmunoTherapy of Cancer

Year:

2020

File:

PDF, 368 KB

2020

36

Neutrophil-to-lymphocyte ratio in combination with PD-L1 or lactate dehydrogenase as biomarkers for high PD-L1 non-small cell lung cancer treated with first-line pembrolizumab

Banna, Giuseppe Luigi, Signorelli, Diego, Metro, Giulio, Galetta, Domenico, De Toma, Alessandro, Cantale, Ornella, Banini, Marco, Friedlaender, Alex, Pizzutillo, Pamela, Garassino, Marina Chiara, Adde

Journal:

Translational Lung Cancer Research

Year:

2020

File:

PDF, 663 KB

2020

37

Efficacy of Pembrolizumab Monotherapy in Patients With or Without Brain Metastases From Advanced NonâSmall Cell Lung Cancer With a PD-L1 Expression â¥50%

Metro, Giulio, Banna, Giuseppe Luigi, Signorelli, Diego, Gili, Alessio, Galetta, Domenico, Galli, Giulia, Economopoulou, Panagiota, Roila, Fausto, Friedlaender, Alex, Camerini, Andrea, Christopoulou,

Journal:

Journal of Immunotherapy

Year:

2020

File:

PDF, 239 KB

2020

38

Reply to Authors

Banna, Giuseppe, Curioni-Fontecedro, Alessandra, Friedlaender, Alex, Addeo, Alfredo

Journal:

Year:

2020

File:

PDF, 275 KB

2020

39

Is clinical effectiveness in the eye of the beholder during the COVID-19 pandemic?

Sandoval, JosÃ© Luis, Friedlaender, Alex, Addeo, Alfredo

Journal:

BMJ Evidence-Based Medicine

Year:

2020

File:

PDF, 112 KB

2020

40

SAKK 19/17: safety analysis of first-line durvalumab in patients with PD-L1 positive, advanced nonsmall cell lung cancer and a performance status of 2

Mark, Michael, Froesch, Patrizia, Eboulet, Eric Innocents, Addeo, Alfredo, Pless, Miklos, Rothschild, Sacha I., Janthur, Wolf-Dieter, Burmeister, Henning, Friedlaender, Alex, Schneider, Martina, Metax

Journal:

Cancer Immunology, Immunotherapy

Year:

2020

File:

PDF, 612 KB

2020

41

Publisher Correction: Clinical outcome of breast cancer in carriers of BRCA1 and BRCA2 mutations according to molecular subtypes

De Talhouet, Solene, Peron, Julien, Vuilleumier, Aurelie, Friedlaender, Alex, Viassolo, Valeria, Ayme, AurÃ©lie, Bodmer, Alexandre, Treilleux, Isabelle, Lang, Noemie, Tille, Jean-Christophe, Chappuis,

Journal:

Scientific Reports

Year:

2020

File:

PDF, 696 KB

2020

42

Steroid Use Independently Predicts for Poor Outcomes in Patients With Advanced NSCLC and High PD-L1 Expression Receiving First-Line Pembrolizumab Monotherapy

Mountzios, Giannis, de Toma, Alessandro, Economopoulou, Panagiota, Friedlaender, Alex, Banini, Marco, Lo Russo, Giuseppe, Baxevanos, Panagiotis, Roila, Fausto, Banna, Giuseppe Luigi, Christopoulou, At

Journal:

Clinical Lung Cancer

Year:

2020

File:

PDF, 1.37 MB

2020